rs121912842
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000094.4(COL7A1):c.6017G>C(p.Gly2006Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2006C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000094.4 missense
Scores
Clinical Significance
Conservation
Publications
- epidermolysis bullosa with congenital localized absence of skin and deformity of nailsInheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dystrophic epidermolysis bullosa pruriginosaInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- recessive dystrophic epidermolysis bullosaInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, ClinGen
- generalized dominant dystrophic epidermolysis bullosaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
- pretibial dystrophic epidermolysis bullosaInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- transient bullous dermolysis of the newbornInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- acral dystrophic epidermolysis bullosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dystrophic epidermolysis bullosa, nails onlyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- recessive dystrophic epidermolysis bullosa inversaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- recessive dystrophic epidermolysis bullosa-generalized otherInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000094.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL7A1 | NM_000094.4 | MANE Select | c.6017G>C | p.Gly2006Ala | missense | Exon 74 of 119 | NP_000085.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL7A1 | ENST00000681320.1 | MANE Select | c.6017G>C | p.Gly2006Ala | missense | Exon 74 of 119 | ENSP00000506558.1 | ||
| COL7A1 | ENST00000328333.12 | TSL:1 | c.6017G>C | p.Gly2006Ala | missense | Exon 73 of 118 | ENSP00000332371.8 | ||
| COL7A1 | ENST00000487017.5 | TSL:5 | n.1934G>C | non_coding_transcript_exon | Exon 39 of 83 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 39
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Epidermolysis bullosa Pathogenic:1
ACMG criteria used: PS4_Moderate, PM1, PM2, PM5, PP3
not provided Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 2006 of the COL7A1 protein (p.Gly2006Ala). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly2006 amino acid residue in COL7A1. Other variant(s) that disrupt this residue have been observed in individuals with COL7A1-related conditions (PMID: 9668111, 14616374), which suggests that this may be a clinically significant amino acid residue. This variant disrupts the triple helix domain of COL7A1. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236), and variants at these glycine residues in COL7A1 are more frequently observed in individuals with disease than in the general population (PMID: 22058051). However, the clinical significance of this observation remains uncertain since only a limited number of affected individuals have been described to date. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL7A1 protein function. This missense change has been observed in individuals with autosomal dominant epidermolysis bullosa dystrophica (PMID: 10504458, 33274474). This variant is not present in population databases (gnomAD no frequency).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at